IL17A and cancer: As such, our findings further highlight the importance of this cross-talk between MMP-9 and IL-17A for cancer cell invasion and migration (as was suggested previously [37]), and they may thus pave the way toward the development of a new generation of cancer inhibitors, based on the dual targeting of inflammatory and extracellular matrix remodeling pathways.